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Transcatheter closure of a large ruptured sinus of Valsalva 
aneurysm to right ventricle — technical challenges
Przezcewnikowe zamknięcie pęknięcia dużego tętniaka zatoki Valsalvy  
do prawej komory — trudności techniczne
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Abstract
Sinus of Valsalva aneurysm, usually a congenital anomaly, almost always ruptures into the right sided cardiac chambers, 
causing a left-to-right shunt with profound haemodynamic consequences. With the availability of the current genera-
tion of devices and hardware, transcatheter closure has gradually replaced the surgical route. To date, most closures 
have been performed using an Amplatzer duct occluder (ADO). Here, we report the case of a 21 year-old male where 
a very large (18 mm) rupture of a sinus of Valsalva aneurysm from non-coronary cusp to right ventricle was closed by 
a percutaneous approach using a 20/18 mm Cocoon duct occluder (CDO; Vascular Innovations, Nonthaburi, Thailand).
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Introduction
A ruptured sinus of Valsalva aneurysm (RSOVA) is a rare 
cardiac abnormality, accounting for < 1% of all congenital 
heart defects. It forms due to a congenital weakness at 
the junction of the aortic media and annulus fibrosus [1]. 
Aneurysms arise from the right coronary sinus (RCS) in 70% 
of cases of RSOVA, from noncoronary sinus (NCS) in 29%, 
and rarely, 1%, from the left coronary sinus [2]. Its presen-
tation varies from asymptomatic findings to the sudden 
onset of chest pain due to acute heart failure associated 
with a severe left-to-right shunt if communicating with the 
right-sided heart chambers, with rapid deterioration cau-
sing death, with a mean survival period for untreated RSOVA 
patients of 1–3.9 years [3]. Early surgical intervention is the 
treatment of choice. Although surgery is the gold standard, 
percutaneous transcatheter closure (TCC) has now become 
equally efficacious, and brings with it fewer complications.
Case report
A 21 year-old manual labourer with no other significant 
comorbidities presented with a history of palpitations 
and breathlessness on exertion of six weeks’ duration. 
On admission, his functional status was New York Heart 
Association (NYHA) class III. On examination, he was 
found to have continuous murmurs in the right second 
and third intercostal spaces, with peripheral signs of 
aortic run-off. Electrocardiogram showed left ventricular 
hypertrophy with right ventricular enlargement, and chest 
X-ray showed mild cardiomegaly with right ventricular 
enlargement. Transthoracic echocardiography showed an-
eurysmally dilated right sinus of Valsalva which was com-
municating into right ventricle (RV) with continuous flow 
revealing a classical windsock deformity. Colour Doppler 
examination revealed a ruptured aneurysm of the right 
coronary sinus of Valsalva causing a large left-to-right 
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shunt into the right ventricle (Figure 1). There were no 
associated defects such as ventricular septum defect or 
aortic regurgitation. Subsequently, it was confirmed on 
aortic root angiogram. This also revealed a mean pul-
monary artery pressure of 58 mmHg and the Qp/Qs was 
2.2. The communication was profiled in different views, 
and the largest diameter was 16–17 mm as measured by 
quantitative coronary analysis (Figure 2). Percutaneous 
device closure was planned with informed consent. The 
right femoral vein and artery and left femoral artery 
were all accessed with 6 F sheaths. Intravenous heparin 
(100 IU/kg) and ceftriaxone-1 gm were injected. The 
defect was crossed from the aortic side using a straight 
tip, 0.035 inch, 190 cm terumo wire (Terumo, Japan) over 
a 6 F Multipurpose diagnostic catheter (MP-1) (Figure 3A). 
Once the wire had reached into the right ventricle (RV), 
the catheter was further advanced into the RV. With the 
Figure 2. Aortic root angiogram showing aneurysmal sac (arrow-
head) of right coronary sinus rupturing into right ventricle. The 
largest diameter of defect was 17 mm
A B C D
Figure 3A–D. The defect was crossed from the aortic side using straight tip terumo wire (A); the wire was exchanged for along terumo wire, 
which was pushed into right atrium where it was snared using a 2 cm EnSnare (B–D)
A
Figure 1A–D. Transthoracic echocardiography showing right sinus of Valsalva communicating into right ventricle (red arrow; A); colour 
Doppler showing the ruptured sinus of Valsalva aneurysm (RSOVA) in right ventricle (B); well apposed device with both the discs (2D echo 
— white arrow; C) (3D; D)
B
C
D
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catheter kept within the RV, the wire was exchanged for 
a long (330 cm, 0.035 inch) terumo wire, which was 
pushed into the right atrium (Figure 3B). It was snared 
using a 2 cm EnSnare (Merit Inc, USA), and brought out 
of the right femoral vein, thereby establishing a stable 
arteriovenous wire loop (Figures 3C, D, 4). As the largest 
diameter of defect was 17 mm, we chose a duct occluder 
device (Cocoon duct occluder, CDO; Vascular Innovations, 
Thailand) of 20/18 mm, meaning that its aortic segment 
was 2 mm larger than the diameter of the defect. As the 
device was compatible with a 12 F sheath, a 6 F venous 
sheath was pulled out and a 12 F long delivery sheath was 
introduced over the terumo exchange length wire from 
the venous side into ascending aorta across the defect. 
As the defect was opening into RV, and sheath being 
12 F, we encountered great difficulty while negotiating 
it beyond the RV into ascending aorta as it tended to 
prolapse back to RV. The long sheath was pulled out and 
another 6 F MP catheter was pushed from venous side 
into descending aorta over the terumo wire. The terumo 
wire was exchanged for a 0.035 inch superstiff Amplatz 
wire (St Jude Med, Germany). This was pushed down to 
descending thoracic aorta where it was snared and bro-
ught out of the femoral artery, thereby creating another 
arterio-venous loop, but this time over the superstiff Am-
platz wire. The long sheath was pushed over the Amplatz 
wire, but again the same difficulty was encountered as it 
tended to prolapse back to RV. Both the ends of Amplatz 
wire were grasped with artery forceps to keep the wire 
taut, and the delivery sheath was pushed with a gentle 
clockwise twist to facilitate its smooth delivery. With the 
help of this manoeuvre, it was successfully pushed bey-
ond the ascending aorta to proximal descending thoracic 
Figure 4. Arteriovenous wire loop was established
A B
Figure 5A, B. 12 F long delivery sheath was pushed beyond the ascending aorta into descending thoracic aorta (white arrow shows the 
bend across right ventricular outflow tract (RVOT), A); aortic end of Cocoon duct occluder (CDO) was positioned to perfectly align with 
the aortic end of the ruptured sinus (B)
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aorta (Figure 5A). CDO, attached to the delivery cable, 
was then inserted into the delivery sheath and pushed 
to open its aortic disc in the ascending aorta. The whole 
assembly was pulled back and positioned carefully until 
the aortic disc perfectly aligned with the aortic end of the 
ruptured sinus. This was ensured after injecting contrast 
through the pigtail catheter which was positioned into 
aortic sinus from the left femoral route. The position was 
ensured via two views: right anterior oblique with cranial 
angulation (RAO cranial), and straight lateral projection 
(Figures 5B, 6A). After confirming the precise placement, 
the rest of the CDO was deployed on the right side across 
the defect by gently pulling the delivery sheath. During 
this manoeuvre, a gentle traction was exerted on the 
delivery cable, but taking special care to ensure that 
the aortic disc was seated on the aortic side, with no 
slippage into the aneurysm. After a 10 minute delay, 
aortic root angiogram was again performed to ensure 
proper device positioning and rule out any para-device 
leak. The CDO was then released from the delivery cable 
by turning the pin-vice anticlockwise (Figure 6B). Device 
position was confirmed and any embolisation was ruled 
out on fluoroscopy (Figure 7). Echocardiogram on the 
following day showed no residual flow across the device 
(Figure 1C, D). The patient was discharged in a stable 
condition the next day on aspirin 75 mg once daily for 
the next six months.
Discussion
Sinus of Valsalva aneurysm almost always ruptures into 
the right side of the heart causing a left-to-right shunt 
with profound haemodynamic effects, especially when the 
rupture is sudden. Most SVAs arise from right coronary 
sinus ruptures in right ventricle and those arising from 
non-coronary sinus ruptures into RA [4]. Since the first 
report of a device closure of a RSOVA in 1994, there have 
been various case reports of RSOVA closure using a patent 
ductus arteriosus (PDA) occluder, a ventricular septal defect 
(VSD) occluder, an atrial septal defect (ASD) occluder, and 
a Rashkind umbrella, for example. Therefore, the transcat-
heter approach has become the gold standard for RSOVA 
if it is amenable to device closure.
The technique is similar to device closure of a per-
imembranous VSD, although the defect is located just 
above the aortic valve instead of below. Sizing of the 
defect can be done by angiographic measurement, and/ 
/or periprocedural echocardiography with colour Doppler 
interrogation which helps in device selection (2–4 mm 
larger than the aortic end). However, echocardiogram also 
gives additional information about its neighbouring stru-
ctures, namely the aortic valve, tricuspid valve, and right 
ventricular outflow tract, and it does the periprocedural 
monitoring of acute aortic, and tricuspid regurgitation, and 
residual shunting. Some authors have also employed the 
Figure 6A, B. Position of the device and complete sealing of the defect was confirmed in straight lateral position as no contrast was flowing 
across the device (A); device position after its deployment (B)
A B
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technique of balloon sizing of the defect to choose the 
appropriate device [5]. In our case, the ruptured RSOVA 
was closed at the aortic end similarly to a ‘surgeon’s 
repair’ since closure at the rupture site (exit point) would 
leave behind an aneurysmal sac which could rupture at 
another site in the long term as it remains exposed to 
arterial pressure [6]. Although the surgical incidence 
of post-procedural aortic regurgitation (AR) is 6%, most 
surgical incidences are based on aortography and not 
on the sensitive colour Doppler modality [7], it was not 
seen in our case. If it is moderate or more, one should 
not perform the device deployment as it speaks of mal-
-coaptation of disc with the aortic sinus. If the degree of 
procedure-related AR is only trivial (less than Grade I), 
it may not be a concern as progression of such AR, if at 
all, is likely to be very gradual and stable over the next 
10–20 years. But it should be serially and closely moni-
tored by transoesophageal echocardiography, and needs 
a longer follow-up than usual.
In our case, the sinus was rupturing into right ventric-
le where the antegrade delivery of the sheath (from right 
atrium to aorta via right ventricle) is sometimes difficult. 
In such a case, one should use an Amplatz superstiff 
wire to make a veno-arterial loop. If this does not work, 
one should tightly grip both ends of the wire with artery 
forceps and gradually push the delivery sheath over the 
wire with a clockwise twist. Once it crosses the right 
ventricle into aorta, it should be pushed as distally as 
possible, at least into the proximal descending aorta, 
as in our case.
The Cocoon duct occluder (CDO) is a platinum-coated, 
self-expandable, mushroom-shaped device made from 
a nitinol wire mesh. Its mushroom-shaped retention 
skirt ensures accurate positioning at the aortic sinus of 
the aneurysm. Multiple poly-propylene patches sewn sec-
urely to the side of the device helps in the introduction of 
thrombosis, thus closes the defect. Nano platinum coating 
prevents nickel leeching into the bloodstream and the 
corrosion of the nitinol wire frame in long term implants. 
Platinum provides better radio-opacity, which enables 
easy positioning of the device in the defect.
TCC of a ruptured sinus of Valsalva can be safely and 
effectively carried out using CDO, and is a good alternative 
to surgery.
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Figure 7A, B. Fluoroscopy showing stable device position (right anterior oblique view, A; straight lateral view, B)
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Streszczenie
Tętniak zatoki Valsalvy, zwykle spowodowany wrodzonym defektem, prawie zawsze pęka, tworząc przetokę do prawo-
stronnych komór serca i powodując przeciek lewo-prawy z poważnymi konsekwencjami hemodynamicznymi. Dzięki 
dostępności najnowszej generacji urządzeń i sprzętu przezcewnikowe zamknięcie przecieku stopniowo zastąpiło drogę 
chirurgiczną. Do tej pory większość zamknięć wykonywano za pomocą urządzenia zamykającego (zapinki) typu Amplat-
zer (ADO, Amplatzer duct occluder). W niniejszej pracy opisano przypadek 21-letniego mężczyzny, u którego metodą 
przezskórną zamknięto pęknięcie bardzo dużego (18 mm) tętniaka niewieńcowej zatoki Valsalvy do prawej komory za 
pomocą urządzenia Cocoon duct occluder 20/18 mm (CDO; Vascular Innovations, Nonthaburi, Tajlandia).
Słowa kluczowe: tętniak zatoki Valsalvy, prawa komora, Amplatzer duct occluder, Cocoon duct occluder, zamknięcie 
przezcewnikowe
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